FINWIRES · TerminalLIVE
FINWIRES

Nyrada Doses First Patient in Phase 2a Trial of Heart Attack Drug Candidate

By

Nyrada (ASX:NYR) has initiated its PROTECT-MI phase 2a clinical trial with the dosing of the first patient evaluating its transient receptor potential canonical ion channel inhibitor Xolatryp, according to a Monday filing with the Australian bourse.

The trial is a randomized, double-blind, placebo-controlled study that will follow patients for 30 days to assess safety, tolerability, and efficacy outcomes while keeping treatment allocation concealed, per the filing.

The company said that trial site activation is progressing, with Sir Charles Gairdner Hospital in Perth expected to begin recruitment soon, additional Australian sites moving through regulatory approval, and expansion into New Zealand underway, the filing said.

The company expects the last patient to be dosed in mid-2027, with top-line results anticipated about three months after that patient completes a 30-day follow-up visit, the filing added.

The company's shares fell 2% in recent Monday trade.

Related Articles

Asia

Greater Bay Area AI Computing Tech Forecasts 240 Million Yuan in H1 Profit

Greater Bay Area AI Computing Tech (HKG:1396) expects a net profit of at least 240 million yuan in the first half of 2026, driven by strong growth in its AI business.The company bagged over 15 billion yuan in new indicative orders for AI computing cloud services in the first half of 2026, according to a Friday Hong Kong bourse filing.As of June 30, the company fulfilled 2 billion yuan of new AI computing cloud service orders.

HKG:1396
Asia

AEON Stores Unit Leases Shop Units in China

AEON Stores (Hong Kong) (HKG:0984) unit AEON (Guangdong) agreed to lease various shops in Yifa Commercial Centre in Guangdong Province, China, according to a Friday Hong Kong bourse filing.The company will lease the premises for 10 years starting Oct. 31 under an agreement with landlord Guangzhou City Yisheng Commercial Investment and property owner Guangzhou City Yingtai Properties.AEON (Guangdong) will use the premises to operate its retail business, the department store operator said.

HKG:0984
Asia

Guotai Haitong Securities Forecasts Up to 304% Surge in Q2 Profit

Guotai Haitong Securities (HKG:2611, SHA:601211) expects attributable profit of between 13.6 billion yuan and 14.1 billion yuan in the second quarter of 2026, up 290% to 304% from 3.5 billion yuan a year prior.For the first half of 2026, it is expected that attributable profit increased by 27% to 30% to between 20 billion yuan and 20.5 billion yuan from 15.7 billion yuan a year prior.The securities and brokerage company attributed the forecast mainly to a higher revenue from the wealth management, investment banking, institution and transaction, investment management, and other business segments.

HKG:2611SHA:601211